Assembly Biosciences, Inc. (ASMB): Price and Financial Metrics


Assembly Biosciences, Inc. (ASMB): $2.19

0.09 (+4.29%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ASMB POWR Grades


  • Growth is the dimension where ASMB ranks best; there it ranks ahead of 81.47% of US stocks.
  • The strongest trend for ASMB is in Growth, which has been heading up over the past 179 days.
  • ASMB ranks lowest in Momentum; there it ranks in the 4th percentile.

ASMB Stock Summary

  • Of note is the ratio of Assembly Biosciences Inc's sales and general administrative expense to its total operating expenses; merely 8.08% of US stocks have a lower such ratio.
  • ASMB's price/sales ratio is 17.7; that's higher than the P/S ratio of 91.97% of US stocks.
  • As for revenue growth, note that ASMB's revenue has grown -92.09% over the past 12 months; that beats the revenue growth of only 1.04% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Assembly Biosciences Inc are APVO, FKWL, HSTO, EMAN, and OIIM.
  • Visit ASMB's SEC page to see the company's official filings. To visit the company's web site, go to www.assemblybio.com.

ASMB Valuation Summary

  • In comparison to the median Healthcare stock, ASMB's price/sales ratio is 26.32% higher, now standing at 4.8.
  • ASMB's price/sales ratio has moved NA NA over the prior 130 months.
  • Over the past 130 months, ASMB's EV/EBIT ratio has gone up 1.4.

Below are key valuation metrics over time for ASMB.

Stock Date P/S P/B P/E EV/EBIT
ASMB 2021-08-31 4.8 0.7 -1.8 -1.3
ASMB 2021-08-30 4.6 0.7 -1.8 -1.2
ASMB 2021-08-27 4.6 0.7 -1.8 -1.2
ASMB 2021-08-26 4.7 0.7 -1.8 -1.2
ASMB 2021-08-25 4.7 0.7 -1.8 -1.2
ASMB 2021-08-24 4.7 0.7 -1.8 -1.3

ASMB Growth Metrics

    Its 2 year revenue growth rate is now at 35.79%.
  • Its 4 year net income to common stockholders growth rate is now at -201.07%.
  • Its 2 year cash and equivalents growth rate is now at -36.76%.
Over the past 70 months, ASMB's revenue has gone up $6,254,000.

The table below shows ASMB's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 6.254 -93.396 -129.855
2021-09-30 7.291 -99.303 -109.016
2021-06-30 35.648 -69.775 -93.562
2021-03-31 75.024 -71.083 -62.697
2020-12-31 79.105 -62.957 -62.152
2020-09-30 82.834 -58.216 -49.818

ASMB's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ASMB has a Quality Grade of D, ranking ahead of 6.92% of graded US stocks.
  • ASMB's asset turnover comes in at 0.126 -- ranking 245th of 682 Pharmaceutical Products stocks.
  • NERV, BLUE, and GTHX are the stocks whose asset turnover ratios are most correlated with ASMB.

The table below shows ASMB's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.126 1 -0.553
2021-03-31 0.258 1 -0.373
2020-12-31 0.264 1 -0.337
2020-09-30 0.264 1 -0.250
2020-06-30 0.179 1 -0.381
2020-03-31 0.058 1 -0.512

ASMB Price Target

For more insight on analysts targets of ASMB, see our ASMB price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $9.71 Average Broker Recommendation 1.71 (Moderate Buy)

ASMB Stock Price Chart Interactive Chart >

Price chart for ASMB

ASMB Price/Volume Stats

Current price $2.19 52-week high $3.94
Prev. close $2.10 52-week low $1.32
Day low $2.06 Volume 218,000
Day high $2.21 Avg. volume 510,160
50-day MA $1.88 Dividend yield N/A
200-day MA $2.22 Market Cap 105.59M

Assembly Biosciences, Inc. (ASMB) Company Bio


Assembly Biosciences develops oral therapies for intractable infectious diseases in the United States. The company focuses on the hepatitis B virus and C. difficile-associated infections. The company was founded in 2005 and is based in New York, New York.


ASMB Latest News Stream


Event/Time News Detail
Loading, please wait...

ASMB Latest Social Stream


Loading social stream, please wait...

View Full ASMB Social Stream

Latest ASMB News From Around the Web

Below are the latest news stories about Assembly Biosciences Inc that investors may wish to consider to help them evaluate ASMB as an investment opportunity.

Assembly Biosciences to Present During the SVB Leerink 11th Annual Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced that John McHutchison, AO, MD, chief executive officer and president, will participate in a virtual fireside chat during the SVB Leerink 11th Annual Global Healthcare Conference on Thursday, February 17, 2022 at 3:40 p.m. ET. A live webcast of

Yahoo | February 9, 2022

Marquette Asset Management, LLC Buys Vanguard Total Bond Market ETF, ARK Next Generation ...

Investment company Marquette Asset Management, LLC (Current Portfolio) buys Vanguard Total Bond Market ETF, ARK Next Generation Internet ETF, TAT Technologies, Avantis International Equity ETF, Dril-Quip Inc, sells Vanguard Short-Term Corporate Bond ETF, Vanguard Total Stock Market ETF, Vanguard FTSE Developed Markets ETF, Concord Acquisition Corp, Astrotech Corp during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Marquette Asset Management, LLC.

Yahoo | January 20, 2022

Assembly Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced grants of stock options to two new employees to purchase an aggregate of 7,000 shares of the Company’s common stock with an exercise price of $2.45 per share, the closing price of Assembly Bio’s common stock on January 3, 2022. The stock option

Yahoo | January 7, 2022

Assembly Biosciences Announces Presentation During the 2022 H.C. Wainwright BIOCONNECT Virtual Conference

SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and other viral diseases, today announced that John McHutchison, AO, MD, chief executive officer and president, will present during the HC Wainwright Virtual BIOCONNECT Conference, January 10-13, 2022. The presentation will be available for on-demand viewing beginning Monday, January 1

Yahoo | January 6, 2022

H.C. Wainwright Remains a Hold on Assembly Biosciences (ASMB)

H.C. Wainwright analyst Ed Arce maintained a Hold rating on Assembly Biosciences (ASMB – Research Report) today and set a price target of $3.50. The company's shares closed last Wednesday at $2.35, close to its 52-week low of $2.03. According to TipRanks.com, Arce is a 5-star analyst with an average return of 16.1% and a 41.8% success rate. Arce covers the Healthcare sector, focusing on stocks such as Entasis Therapeutics Holdings, Madrigal Pharmaceuticals, and Paratek Pharmaceuticals. Currently, the analyst consensus on Assembly Biosciences is a Moderate Buy with an average price target of $9.88.

Howard Kim on TipRanks | January 5, 2022

Read More 'ASMB' Stories Here

ASMB Price Returns

1-mo 12.31%
3-mo 6.31%
6-mo -10.61%
1-year -40.33%
3-year -84.82%
5-year -89.41%
YTD -6.01%
2021 -61.49%
2020 -70.43%
2019 -9.55%
2018 -50.01%
2017 272.43%

Continue Researching ASMB

Want to see what other sources are saying about Assembly Biosciences Inc's financials and stock price? Try the links below:

Assembly Biosciences Inc (ASMB) Stock Price | Nasdaq
Assembly Biosciences Inc (ASMB) Stock Quote, History and News - Yahoo Finance
Assembly Biosciences Inc (ASMB) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9798 seconds.